132 related articles for article (PubMed ID: 37670705)
21. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.
Campos X; Muñoz Y; Selman A; Yazigi R; Moyano L; Weinstein-Oppenheimer C; Lara HE; Romero C
Gynecol Oncol; 2007 Jan; 104(1):168-75. PubMed ID: 16935322
[TBL] [Abstract][Full Text] [Related]
22. The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.
Farina AR; Cappabianca L; Ruggeri P; Gneo L; Pellegrini C; Fargnoli MC; Mackay AR
J Exp Clin Cancer Res; 2018 Jun; 37(1):119. PubMed ID: 29914559
[TBL] [Abstract][Full Text] [Related]
23. Timing of NTRK Gene Fusion Testing and Treatment Modifications Following TRK Fusion Status Among US Oncologists Treating TRK Fusion Cancer.
Klink AJ; Kavati A; Gassama AT; Kozlek T; Gajra A; Antoine R
Target Oncol; 2022 May; 17(3):321-328. PubMed ID: 35716252
[TBL] [Abstract][Full Text] [Related]
24. A novel apoptotic pathway induced by nerve growth factor-mediated TrkA activation in medulloblastoma.
Chou TT; Trojanowski JQ; Lee VM
J Biol Chem; 2000 Jan; 275(1):565-70. PubMed ID: 10617652
[TBL] [Abstract][Full Text] [Related]
25. Nerve growth factor signaling involves interaction between the Trk A receptor and lysophosphatidate receptor 1 systems: nuclear translocation of the lysophosphatidate receptor 1 and Trk A receptors in pheochromocytoma 12 cells.
Moughal NA; Waters C; Sambi B; Pyne S; Pyne NJ
Cell Signal; 2004 Jan; 16(1):127-36. PubMed ID: 14607283
[TBL] [Abstract][Full Text] [Related]
26. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer.
Ma J; Jiang Y; Jiang Y; Sun Y; Zhao X
J Gastroenterol Hepatol; 2008 Dec; 23(12):1852-9. PubMed ID: 19120874
[TBL] [Abstract][Full Text] [Related]
27. Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1.
York RD; Molliver DC; Grewal SS; Stenberg PE; McCleskey EW; Stork PJ
Mol Cell Biol; 2000 Nov; 20(21):8069-83. PubMed ID: 11027277
[TBL] [Abstract][Full Text] [Related]
28. Nerve growth factor signals through TrkA, phosphatidylinositol 3-kinase, and Rac1 to inactivate RhoA during the initiation of neuronal differentiation of PC12 cells.
Nusser N; Gosmanova E; Zheng Y; Tigyi G
J Biol Chem; 2002 Sep; 277(39):35840-6. PubMed ID: 12133829
[TBL] [Abstract][Full Text] [Related]
29. Nerve growth factor & TrkA as novel therapeutic targets in cancer.
Demir IE; Tieftrunk E; Schorn S; Friess H; Ceyhan GO
Biochim Biophys Acta; 2016 Aug; 1866(1):37-50. PubMed ID: 27264679
[TBL] [Abstract][Full Text] [Related]
30. NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number.
Woo CW; Lucarelli E; Thiele CJ
Oncogene; 2004 Feb; 23(8):1522-30. PubMed ID: 14691455
[TBL] [Abstract][Full Text] [Related]
31. TrkA pathway(s) is involved in regulation of TRPM7 expression in hippocampal neurons subjected to ischemic-reperfusion and oxygen-glucose deprivation.
Jiang H; Tian SL; Zeng Y; Li LL; Shi J
Brain Res Bull; 2008 May; 76(1-2):124-30. PubMed ID: 18395621
[TBL] [Abstract][Full Text] [Related]
32. TrkA overexpression enhances growth and metastasis of breast cancer cells.
Lagadec C; Meignan S; Adriaenssens E; Foveau B; Vanhecke E; Romon R; Toillon RA; Oxombre B; Hondermarck H; Le Bourhis X
Oncogene; 2009 May; 28(18):1960-70. PubMed ID: 19330021
[TBL] [Abstract][Full Text] [Related]
33. TRK inhibitors in TRK fusion-positive cancers.
Drilon A
Ann Oncol; 2019 Nov; 30 Suppl 8():viii23-viii30. PubMed ID: 32223935
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Brodeur GM
Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
[TBL] [Abstract][Full Text] [Related]
35. Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer.
Zhu Z; Friess H; diMola FF; Zimmermann A; Graber HU; Korc M; Büchler MW
J Clin Oncol; 1999 Aug; 17(8):2419-28. PubMed ID: 10561305
[TBL] [Abstract][Full Text] [Related]
36. Persistent TrkA activity is necessary to maintain transcription in neuronally differentiated PC12 cells.
Chang JH; Mellon E; Schanen NC; Twiss JL
J Biol Chem; 2003 Oct; 278(44):42877-85. PubMed ID: 12909622
[TBL] [Abstract][Full Text] [Related]
37. NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib.
Aubert L; Guilbert M; Corbet C; Génot E; Adriaenssens E; Chassat T; Bertucci F; Daubon T; Magné N; Le Bourhis X; Toillon RA
Oncotarget; 2015; 6(12):9807-19. PubMed ID: 25840418
[TBL] [Abstract][Full Text] [Related]
38. A double cysteine trkA mutant exhibiting reduced NGF binding and delayed Erk signaling.
Jiang H; Movsesyan V; Liu XW; Katagiri Y; Monshipoyri M; Lazarovici P
J Mol Neurosci; 2001 Dec; 17(3):293-302. PubMed ID: 11859925
[TBL] [Abstract][Full Text] [Related]
39. Nerve growth factor receptor TrkA signaling in breast cancer cells involves Ku70 to prevent apoptosis.
Com E; Lagadec C; Page A; El Yazidi-Belkoura I; Slomianny C; Spencer A; Hammache D; Rudkin BB; Hondermarck H
Mol Cell Proteomics; 2007 Nov; 6(11):1842-54. PubMed ID: 17617666
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Tropomyosin Receptor Kinase A Signaling Negatively Regulates Megakaryopoiesis and induces Thrombopoiesis.
Kizilyer A; Singh MV; Singh VB; Suwunnakorn S; Palis J; Maggirwar SB
Sci Rep; 2019 Feb; 9(1):2781. PubMed ID: 30808933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
